8-K
Revvity Reports Third Quarter 2026 Results and Raises Full Year Guidance
8-K
Revvity Reports Second Quarter 2026 Financial Results and Announces Divestiture of China Immunodiagnostics Business
8-K
Revvity Announces First Quarter 2026 Financial Results and Intention to Divest China Immunodiagnostics Business
8-K
Revvity, Inc. Announces Results of 2026 Annual Meeting of Shareholders
8-K
Revvity Reports Q4 and Full Year 2025 Financial Results and Issues 2026 Guidance
8-K
Revvity to Announce Q4 and Full Year 2025 Results on February 2, 2026